Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas ... pegRNA scaffold incorporation is a common by-product of prime editing, compromising its precision and safety. Here, the authors show that ...

Deanna earned their PhD in cellular biology from McGill University in 2020 and has a professional background in medical writing. They are an associate science editor at The Scientist. View Full ...

When the CRISPR Cas9 protein is added to a cell along with a piece of guide RNA, the Cas9 protein hooks up with the guide RNA and then moves along the strands of DNA until it finds and binds to a ...

The company’s lead product candidate is CASGEVY, an ex vivo CRISPR/Cas9 gene-edited cell therapy for treating patients suffering from transfusion-dependent beta-thalassemia, severe sickle cell ...

The agreement grants Jumpcode access to ERS' CRISPR/Cas9 patent portfolio, empowering the company to advance the sensitivity and efficiency of next-generation sequencing (NGS) and expand ...

Nona Biosciences, announced that it has entered into a multi-target antibody discovery collaboration with Umoja Biopharma. This collaboration leverages Nona's proprietary fully human heavy chain only ...